C

CG Oncology Inc
NASDAQ:CGON

Watchlist Manager
CG Oncology Inc
NASDAQ:CGON
Watchlist
Price: 40.14 USD 0.22% Market Closed
Market Cap: 3.2B USD

Wall Street
Price Targets

CGON Price Targets Summary
CG Oncology Inc

Wall Street analysts forecast CGON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CGON is 72.97 USD with a low forecast of 55.55 USD and a high forecast of 105 USD.

Lowest
Price Target
55.55 USD
38% Upside
Average
Price Target
72.97 USD
82% Upside
Highest
Price Target
105 USD
162% Upside
CG Oncology Inc Competitors:
Price Targets
XFOR
X4 Pharmaceuticals Inc
87% Upside
COV
Covalon Technologies Ltd
71% Upside
SVRA
Savara Inc
64% Upside
BVXP
Bioventix PLC
121% Upside
DVAX
Dynavax Technologies Corp
38% Upside
4BB
4Basebio PLC
182% Upside
CUV
Clinuvel Pharmaceuticals Ltd
105% Upside
ASND
Ascendis Pharma A/S
30% Upside

Revenue
Forecast

Revenue Estimate
CG Oncology Inc

For the last 2 years the compound annual growth rate for CG Oncology Inc's revenue is 144%. The projected CAGR for the next 4 years is 332%.

144%
Past Growth
332%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
CG Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CG Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CGON's stock price target?
Price Target
72.97 USD

According to Wall Street analysts, the average 1-year price target for CGON is 72.97 USD with a low forecast of 55.55 USD and a high forecast of 105 USD.

What is CG Oncology Inc's Revenue forecast?
Projected CAGR
332%

For the last 2 years the compound annual growth rate for CG Oncology Inc's revenue is 144%. The projected CAGR for the next 4 years is 332%.

Back to Top